We are live on
!
Find out more
BG
Bollard Group Portfolio holdings
AUM
$3.39B
1-Year Est. Return
1.06%
This Fund
S&P 500
This Quarter
Est. Return
+6.36%
1 Year Est. Return
-1.06%
3 Year Est. Return
+72.63%
5 Year Est. Return
+112.03%
10 Year Est. Return
+415.67%
AUM
$4.37B
AUM Growth
+$566M
(+15%)
Cap. Flow
+$197M
Cap. Flow
% of AUM
4.52%
Top 10 Holdings %
Top 10 Hldgs %
75.62%
Holding
311
New
26
Increased
196
Reduced
22
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$25.9M |
| 2 |
Madison Square Garden
MSGS
|
+$23.3M |
| 3 |
Microsoft
MSFT
|
+$14.8M |
| 4 |
Amazon
AMZN
|
+$12.7M |
| 5 |
NVIDIA
NVDA
|
+$12.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$41.6M |
| 2 |
HF Sinclair
DINO
|
+$6.4M |
| 3 |
UnitedHealth
UNH
|
+$3.72M |
| 4 |
Tortoise North American Pipeline ETF
TPYP
|
+$2.48M |
| 5 |
Diamondback Energy
FANG
|
+$2.11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 56.07% |
| 2 | Technology | 8.45% |
| 3 | Energy | 6.73% |
| 4 | Consumer Discretionary | 4.64% |
| 5 | Utilities | 4.37% |
Similar funds
BCM
OAM
MCM
DFO
VFCM
EFM
WS
DIA
Bollard Group's Q2 2025 Portfolio in Review
As of Q2 2025, Bollard Group held 311 positions worth $4.37B, up 15% from $3.81B the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Bollard Group deployed $197M of net new capital in Q2 2025, opening 26 new positions and adding to 196 existing holdings. Its largest new stake was Madison Square Garden: 121,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Healthcare at 56% of assets, down from 61% a quarter earlier, followed by Technology and Energy.
On the sell side, the largest reduction was Boston Scientific, an estimated $41.6M trimmed.
- Bollard Group's largest Q2 2025 buy was Madison Square Garden: 121,000 shares worth $25.3M.
- Bollard Group added most to Thermo Fisher Scientific in Q2 2025, an estimated $25.9M increase.
- Bollard Group's biggest Q2 2025 reduction was Boston Scientific, cutting an estimated $41.6M.
- Bollard Group fully exited HF Sinclair in Q2 2025, selling an estimated $6.4M.
- Bollard Group's ten largest holdings make up 76% of its $4.37B portfolio in Q2 2025.
- Bollard Group opened 26 new positions and closed 17 in Q2 2025.
- Bollard Group's portfolio value rose 15% quarter-over-quarter to $4.37B.
Based on Bollard Group's 13F filing for Q2 2025, filed 13 Aug 2025.